China’s drug industry pivots to AI-powered candidates to drive next wave of deals

South China Morning Post

After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towards artificial intelligence-powered candidates to drive the next wave of transactions.
China accounted for about 30 per cent of all new drugs currently under development worldwide, ranking second globally, according to Lan Gongtao, deputy director general of the Department of Drug Registration at the National Medical Products Administration.
China’s...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

China’s drug industry pivots to AI-powered candidates to drive next wave of deals

이 뉴스, 어떠셨어요?

관련 뉴스

'world' 카테고리 뉴스

3 dead, 6 missing in Davao Occidental flash floods

Palace hits Baste Duterte’s claim impeach meant to derail Sara 2028 bid

Lava fountaining recorded in Mayon Volcano

South China Morning Post의 다른 기사

Hongkongers spend record HK$2,000 per month on cats as ‘silver’ feline market grows

Italian chef handed 90 hours of community service for drink-driving, speeding

Futu expects mainland brokerage business to shrink but vows to keep Hong Kong outlets